{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["bacteria", "in vitro antimicrobial activity", "ocular infections", "ozonated oil"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "35795001", "DateRevised": {"Year": "2023", "Month": "09", "Day": "16"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "06", "Day": "07"}], "ELocationID": ["10.1515/med-2022-0495"], "Journal": {"ISSN": "2391-5463", "JournalIssue": {"Volume": "17", "Issue": "1", "PubDate": {"Year": "2022"}}, "Title": "Open medicine (Warsaw, Poland)", "ISOAbbreviation": "Open Med (Wars)"}, "ArticleTitle": "<i>In vitro</i> antimicrobial activity of ozonated oil in liposome eyedrop against multidrug-resistant bacteria.", "Pagination": {"StartPage": "1057", "EndPage": "1063", "MedlinePgn": "1057-1063"}, "Abstract": {"AbstractText": ["Bacteria are the most common causative agents of ocular infections. Treatment with topical broad-spectrum antibiotics is recommended in severe cases. However, antibiotic resistance has become a major concern in recent years, although antibiotics are generally effective in treating ocular infections. Antibacterial compound screening is performed to identify alternative therapeutic options to antibiotics. The aim of this study was to assess the <i>in vitro</i> antimicrobial activity of an ophthalmic solution containing ozonated oil. Strains of bacterial species with a multidrug resistance profile, which are responsible for a large proportion of ocular infections, were isolated and selected from different biological samples. The bacterial isolates were cultured, and ozonated oil was used to evaluate the inhibition zones at different time points. The treatment exhibited antibacterial activity against all the tested species. The effect was lower against the strains of <i>Pseudomonas aeruginosa</i> and more evident against <i>Staphylococcus</i> and <i>Streptococcus</i> spp. Our results suggest that the administration of ozonated oil may be a candidate agent to treat some infections of the ocular surface with a potential role in antimicrobial prophylaxis."], "CopyrightInformation": "\u00a9 2022 Giuseppe Grandi et al., published by De Gruyter."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbiology and Virology Unit, University Hospital Citt\u00e0 della Salute e della Scienza di Torino, Turin, 10126, Italy."}], "LastName": "Grandi", "ForeName": "Giuseppe", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbiology and Virology Unit, University Hospital Citt\u00e0 della Salute e della Scienza di Torino, Turin, 10126, Italy."}], "LastName": "Cavallo", "ForeName": "Rossana", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbiology and Virology Unit, University Hospital Citt\u00e0 della Salute e della Scienza di Torino, Turin, 10126, Italy."}], "LastName": "Zanotto", "ForeName": "Elisa", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbiology and Virology Unit, Amedeo di Savoia Hospital, Turin, 10149, Italy."}], "LastName": "Cipriani", "ForeName": "Raffaella", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ophthalmology Unit, Humanitas Gradenigo Hospital, Turin, 10153, Italy."}], "LastName": "Panico", "ForeName": "Claudio", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ophthalmic Unit, Hospital San Biagio, Domodossola, 28845, Italy."}], "LastName": "Protti", "ForeName": "Romolo", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine and Health Sciences \"V. Tiberio\", University of Molise, Via V. De Sanctis, s.n.c., Campobasso 86100, Italy."}], "LastName": "Scapagnini", "ForeName": "Giovanni", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine and Health Sciences \"V. Tiberio\", University of Molise, Via V. De Sanctis, s.n.c., Campobasso 86100, Italy."}], "LastName": "Davinelli", "ForeName": "Sergio", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine and Health Sciences \"V. Tiberio\", University of Molise, Via V. De Sanctis, s.n.c., Campobasso 86100, Italy."}], "LastName": "Costagliola", "ForeName": "Ciro", "Initials": "C"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Poland", "MedlineTA": "Open Med (Wars)", "NlmUniqueID": "101672167"}, "CoiStatement": "Conflict of interest: Sergio Davinelli become Editor in Open Medicine from March, but this fact hasnt impacted the peer-review process."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wilcox HD. Characterization of the normal microbiota of the ocular surface. Exp Eye Res. 2013;117:99\u2013105. 10.1016/j.exer.2013.06.003.", "ArticleIdList": ["10.1016/j.exer.2013.06.003", "23797046"]}, {"Citation": "Dong Q, Brulc JM, Iovieno A, Bates B, Garoutte A, Miller D, et al. Diversity of bacteria healthy at humans conjunctiva. Invest Ophthalmol Vis Sci. 2011;52(8):5408\u201313. 10.1167/iovs.10-6939.", "ArticleIdList": ["10.1167/iovs.10-6939", "PMC3176057", "21571682"]}, {"Citation": "Shin H, Price K, Albert L, Dodick J, Park L, Dominguez-Bello MG. Changes in the eye microbiota associated with contact lens wearing. mBIO. 2016;7(2):e00198\u2013216. 10.1128/mBio.00198-16.", "ArticleIdList": ["10.1128/mBio.00198-16", "PMC4817251", "27006462"]}, {"Citation": "Ozkan J, Nielsen S, Diez-Vives C, Coroneo M, Thomas T, Willcox M. Temporal stability and composition of the ocular surface microbiome. Sci Rep. 2017;7(1):9880. 10.1038/s41598-017-10494-9.", "ArticleIdList": ["10.1038/s41598-017-10494-9", "PMC5575025", "28852195"]}, {"Citation": "Foulsham W, Coco G, Amouzegar A, Chauhan SK, Dana R. When clarity is crucial: regulating surface immunity. Trends Immunol. 2018;39(4):288\u2013301. 10.1016/j.it.2017.11.007.", "ArticleIdList": ["10.1016/j.it.2017.11.007", "PMC5880704", "29248310"]}, {"Citation": "Allansmith M. Immunology of tears. Int Ophthalmol Clin. 1973;13(1):47\u201372. 10.1097/00004397-197301310-00006.", "ArticleIdList": ["10.1097/00004397-197301310-00006", "4135039"]}, {"Citation": "Dor M, Eperon S, Lalive PH, Guex-Crosier Y, Hamedani M, Salvisberg C, et al. Investigation of the global protein content from human tears. Exp Eye Res. 2019;179:64\u201374. 10.1016/j.exer.2018.10.006.", "ArticleIdList": ["10.1016/j.exer.2018.10.006", "30321513"]}, {"Citation": "Kijstra A, Kuizega A, van Der Velde M, Haeringen NJ. Gel electrophoresis of human tears reveals various forms of tear lactoferrin. Curr Eye Res. 1989;8(6):581\u20138. 10.3109/02713688908995757.", "ArticleIdList": ["10.3109/02713688908995757", "2743797"]}, {"Citation": "Grandi G, Bianco G, Boattini M, Scalabrin S, Iannaccone M, Fea A, et al. Bacterial etiology and antimicrobial resistance trends in ocular infections: a 30 \u2013year study, Turin area, Italy. Eur J Ophthalmol. 2021;31(2):405\u201314. 10.1177/1120672119896419.", "ArticleIdList": ["10.1177/1120672119896419", "31875683"]}, {"Citation": "Teweldemedhin M, Gebreyesus H, Atsbaha AH, Asgedom SW, Saravanan M. Bacterial profile of ocular infections: a systematic review. BMC Ophthalmol. 2017;17(1):212. 10.1186/s12886-017-0612-2.", "ArticleIdList": ["10.1186/s12886-017-0612-2", "PMC5702129", "29178851"]}, {"Citation": "Giardini F, Grandi G, De Sanctis U, Eandi C, Machetta F, Pollino C, et al. In vitro susceptibility to different topical antibiotics of bacterial isolates from patients with conjunctivitis. Ocul Immunol Inflamm. 2011;19(6):419\u201321. 10.3109/09273948.2011.624289.", "ArticleIdList": ["10.3109/09273948.2011.624289", "22106909"]}, {"Citation": "Azari AA, Barney NP. Conjunctivitis a systemic review of diagnosis and treatment. JAMA. 2013;310(16):1721\u20139. 10.1001/jama.2013.280318.", "ArticleIdList": ["10.1001/jama.2013.280318", "PMC4049531", "24150468"]}, {"Citation": "Bremon-Gignac D, Chiambaretta F, Milazzo S. European perspective on topical ophthalmic antibiotics:current and evolving options. Ophthalmol Eye Dis. 2011;3:29\u201343. 10.4137/OED.S4866.", "ArticleIdList": ["10.4137/OED.S4866", "PMC3661455", "23861622"]}, {"Citation": "Peng MY, Cevallos V, Mc Leod SD, Lietman TM, Rose-Nussbaumer J. Bacterial keratitis: isolate organisms and antibiotic resistence patterns in San Francisco. Cornea. 2018;37(1):84\u20137. 10.1097/ICO.0000000000001417.", "ArticleIdList": ["10.1097/ICO.0000000000001417", "PMC5716884", "29053557"]}, {"Citation": "Sand D, She R, Shulman IA, Schur M, Hsu HY. Microbial keratitis in los angeles country hospital institute and the los angeles country hospital experience. Ophthalmology. 2015;122(5):918\u201324. 10.1016/j.ophtha.2014.11.027.", "ArticleIdList": ["10.1016/j.ophtha.2014.11.027", "25600200"]}, {"Citation": "Ting DSJ, Settle C, Morgan SJ, Baylis O, Ghosh S. A 10 years analysis of microbiological profiles of microbial keratitis: the north east England study. Eye. 2018;32(8):1416\u20137. 10.1038/s41433-018-0085-4.", "ArticleIdList": ["10.1038/s41433-018-0085-4", "PMC6085375", "29610521"]}, {"Citation": "Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea. 2008;27(1):22\u20137. 10.1097/ICO.0b013e318156caf2.", "ArticleIdList": ["10.1097/ICO.0b013e318156caf2", "18245962"]}, {"Citation": "Pachigolla G, Blomquist C, Cavangh HD. Microbial keratitis pathogens and antibiotic susceptibilities: a 5 years review of cases at an urban country hospital in north texas. Eye Contact lens. 2007;33(1):45\u20139. 10.1097/01.icl.0000234002.88643.d0.", "ArticleIdList": ["10.1097/01.icl.0000234002.88643.d0", "17224678"]}, {"Citation": "Attisano C, Cibinel M, Strani G, Panepinto G, Pollino C, Furfaro G. Severe ocular bacterial infections: a retrospective study over 13 years. Ocul Immunol Inflamm. 2017;25(6):826\u20139. 10.1080/09273948.2016.1181767.", "ArticleIdList": ["10.1080/09273948.2016.1181767", "27438306"]}, {"Citation": "Moconey TP, Park J. Microbiological isolates and antibiotic sensitivities in culture- proven endophthalmitis: a 15 years review. Br J Ophthalmol. 2014;98(11):1492\u20137. 10.1136/bjophthalmol-2014-305030.", "ArticleIdList": ["10.1136/bjophthalmol-2014-305030", "24939423"]}, {"Citation": "Durand ML. Endophthalmitis. Clin Microbiol Infec. 2013;19(3):227\u201334. 10.1111/1469-0691.12118.", "ArticleIdList": ["10.1111/1469-0691.12118", "PMC3638360", "23438028"]}, {"Citation": "Masterton RG. The new treatment paradigm and the role of carbapenems. Int J Antimicrob Agents. 2009;33(2):105\u201310. 10.1016/j.ijantimicag.2008.07.023.", "ArticleIdList": ["10.1016/j.ijantimicag.2008.07.023", "18848436"]}, {"Citation": "Asbell PA, Colby KA, Deng S, McDonnell P, Meisler DM, Raizman MB. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am J Ophthalmol. 2008;145(6):951\u20138. 10.1016/j.ajo.2008.01.025.", "ArticleIdList": ["10.1016/j.ajo.2008.01.025", "18374299"]}, {"Citation": "Asbel PA, Sham DF, Shaw M, Draghi DC, Brown NP. Increasing prevalence of methicillin resistance in serious ocular infections caused by staphylococcus aureus in the united states: 2000 to 2005. J Cataract Refract Surg. 2008;34(5):814\u20138. 10.1016/j.jcrs.2008.01.016.", "ArticleIdList": ["10.1016/j.jcrs.2008.01.016", "18471638"]}, {"Citation": "Bandello F, Coassin M, Di Zazzo A, Rizzo S, Biagini I, Pozdeyeva N, et al. One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy. Eye. 2020;34(11):2112\u201322. 10.1038/s41433-020-0869-1.", "ArticleIdList": ["10.1038/s41433-020-0869-1", "PMC7785009", "32366996"]}, {"Citation": "Asbel PA, Pandit RT, Sanfilippo CM. Antibiotic resistence rates by geographic region among ocular pathogens collected during the ARMOR surveillance study. Ophthalmol Ther. 2018;7(2):417\u201329. 10.1007/s40123-018-0141-y.", "ArticleIdList": ["10.1007/s40123-018-0141-y", "PMC6258574", "30094698"]}, {"Citation": "Bertino JS. Impact of antibiotic resistence in the management of ocular infections: the role of current and future antibiotics. Cilin Ophthalmol. 2009;3:507\u201321. 10.2147/opth.s5778.", "ArticleIdList": ["10.2147/opth.s5778", "PMC2754082", "19789660"]}, {"Citation": "Tognetto D, Pastore MR, Guerin GM, Decorti G, Franzin M, Lagatolla C, et al. Bactericidal activity of three different antiseptic ophthalmic preparations as surgical prophylaxis. Graefes Arch Clin Exp Ophthalmol. 2022;260(1):289\u201393. 10.1007/s00417-021-05361-3.", "ArticleIdList": ["10.1007/s00417-021-05361-3", "PMC8763824", "34427741"]}, {"Citation": "Gupta G, Mansi B. Ozone therapy in periodontics. J Med Life. 2012;5(1):59\u201367.", "ArticleIdList": ["PMC3307081", "22574088"]}, {"Citation": "Pietrocola G, Ceci M, Preda F, Poggio C, Colombo M. Evaluation of the antibacterial activity of a new ozonated olive oil against oral and peridontal pathogens. J Clin Exp Dent. 2018;10(11):e1103\u20138. 10.4317/jced.54929.", "ArticleIdList": ["10.4317/jced.54929", "PMC6311406", "30607228"]}, {"Citation": "Martinez SG, Al-Dalain SM, Menendez S, Re L, Giuliani A, Candelario-Jalil E. Therapeutic efficacy of ozone in patients with diabetic food. Eur J Pharm. 2005;523(1\u20133):151\u201361. 10.1016/j.ejphar.2005.08.020.", "ArticleIdList": ["10.1016/j.ejphar.2005.08.020", "16198334"]}, {"Citation": "Fizpatrick E, Holland OJ, Vanderleilie JJ. Ozone therapy for the treatment of cronin wounds: A systematic review. Int Wound J. 2018;15(4):633\u201344. 10.1111/iwj.12907.", "ArticleIdList": ["10.1111/iwj.12907", "PMC7949634", "29536625"]}, {"Citation": "Serio F, Alba M, Cozzolino G, Idolo A, Grassi T, Bagordo F, et al. Efficacy of a dermatological gel based on ozonated sunflower seed oil (Oz.Or.Oil 30) on bedsores: A pilot study. Clin Derm Res J. 2017;2:2."}, {"Citation": "Marchegiani A, Magagnini M, Cerquetella M, Troiano P, Franchini I, Franchini A. Preoperative topical liposomal ozone dispersion to reduce bacterial colonization in conjunctival sac and periocular skin: Preliminary study in dogs. Exp Eye Res. 2019;189:107848. 10.1016/j.exer.2019.107848.", "ArticleIdList": ["10.1016/j.exer.2019.107848", "31634477"]}, {"Citation": "Celenza G, Iorio R, Cracchiolo S, Petricca S, Costagliola C, Cinque B. Antimycotic activity of ozonated oil in liposome eye drops against candida spp. Transl Vis Sci Technol. 2020;9(8):4. 10.1167/tvst.9.8.4.", "ArticleIdList": ["10.1167/tvst.9.8.4", "PMC7422790", "32855851"]}, {"Citation": "Spadea L, Tonti E, Spaterna A, Marchegiani A. Use of ozone-based eye drops: A series of cases in veterinary and human spontaneous ocular pathologies. Case Rep Ophthalmol. 2018;9(2):287\u201398. 10.1159/000488846.", "ArticleIdList": ["10.1159/000488846", "PMC6006625", "29928225"]}, {"Citation": "Ugazio S, Vivian T, Binello A, Tagliapietra S, Dosio F. Ozonated oils as antimicrobial system in topical applications. Their characterisation, current applications, and advances in improved delivery tachniques. Molecules. 2020;25(2):334. 10.3390/molecules25020334.", "ArticleIdList": ["10.3390/molecules25020334", "PMC7024311", "31947580"]}, {"Citation": "Nagayoshi M, Fukuizumi T, Kitamura M, Nagayoshi M, Fukuizumi T, Kitamura M. Efficacy of ozone on survival and permeability of oral microorganisms. Oral Microbiol Immunol. 2004;19(4):240\u20136. 10.1111/j.1399-302X.2004.00146.x.", "ArticleIdList": ["10.1111/j.1399-302X.2004.00146.x", "15209994"]}, {"Citation": "Moureau S, Violleau F, Ali Haimuod-Lekhal D, Calmon A. Ozonation of sunflowers oils: Impact of experimental conditions on the composition and the antibacterial activity of ozonated oils. Chem Phys Lipids. 2015;186:79\u201385. 10.1016/j.chemphyslip.2015.01.004.", "ArticleIdList": ["10.1016/j.chemphyslip.2015.01.004", "25623845"]}, {"Citation": "Carata E, Tenuzzo BA, Dini L. Powerful properties of ozonated extra virgin olive oil. In: Builders PF, editor. Herbal medicine. London: IntechOpen; 2018. #https://www.intechopen.com/chapters/58960.10.5772/intechopen.73211.", "ArticleIdList": ["10.5772/intechopen.73211"]}, {"Citation": "Zeng J, Lu J. Mechanisms of action involved in ozone-therapy in skin diseases. Int Immunopharmacol. 2018;56:235\u201341. 10.1016/j.intimp.2018.01.040.", "ArticleIdList": ["10.1016/j.intimp.2018.01.040", "29414657"]}, {"Citation": "Harada T. Olive oil ozonide and its fungicidal quality. Bull Chem Soc Jpn. 1934;9:192\u20137."}, {"Citation": "Song M, Zeng Q, Xiang Y, Gao L, Huang J, Huang J. The antibacterial effect of topical ozone on the treatment of MRSA skin infection. Mol Med Rep. 2017;17(2):2449\u201355. 10.3892/mmr.2017.8148.", "ArticleIdList": ["10.3892/mmr.2017.8148", "PMC5783482", "29207120"]}, {"Citation": "Zanardi I, Burgassi S, Paccagnini E, Gentile M, Bocci V, Travagli V. What is the best strategy for enhancing the effects of topically applied ozonated oils in cutaneous infections? Biomed Res Int. 2013;2013:702949. 10.1155/2013/702949.", "ArticleIdList": ["10.1155/2013/702949", "PMC3825054", "24282818"]}, {"Citation": "Azari AA, Barney NP. Conjunctivitis a systematic review of diagnosis and treatment. JAMA. 2013;310(16):1721\u20139. 10.1001/jama.2013.280318.", "ArticleIdList": ["10.1001/jama.2013.280318", "PMC4049531", "24150468"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "13"}, {"Year": "2022", "Month": "5", "Day": "8"}, {"Year": "2022", "Month": "5", "Day": "9"}, {"Year": "2022", "Month": "7", "Day": "7", "Hour": "2", "Minute": "17"}, {"Year": "2022", "Month": "7", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "8", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "6", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["35795001", "PMC9175013", "10.1515/med-2022-0495", "med-2022-0495"]}}], "PubmedBookArticle": []}